Praxis Precision Med Price Target Maintained With a $270.00/Share by Piper Sandler

Praxis Precision Med Price Target Maintained With a $270.00/Share by Piper Sandler

Dow JonesJul 1 22:00

Piper Sandler Initiates a Buy Rating on Praxis Precision Medicines (PRAX)

TipRanksJul 1 18:36

Value Of Praxis Precision Medicines' Lead Program In Essential Tremor Alone Is Underappreciated: Analyst

Needham initiated coverage on Praxis Precision Medicines Inc (NASDAQ:PRAX), a clinical-stage biopharmaceutical company, engaged in the development of therapies for central nervous system disorders.The

BenzingaJun 25 03:54

Needham Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $145

Needham analyst Ami Fadia initiates coverage on $Praxis Precision Medicines(PRAX.US)$ with a buy rating, and sets the target price at $145.According to TipRanks data, the analyst has a success rate of

Futu NewsJun 24 18:31 · Ratings

Praxis Precision Med Initiated at Buy by Needham

Praxis Precision Med Initiated at Buy by Needham

Dow JonesJun 24 17:47

Express News | Praxis Precision Medicines Inc : Needham Initiates Coverage With Buy Rating; Price Target $145

BreakingsJun 24 17:39